Relay Therapeutics (RLAY) Acquisitions (2021)

Relay Therapeutics' (RLAY) quarterly Acquisitions came in at $83000.0 in Q4 2021, little changed on a QoQ basis from $83000.0 in Q3 2021.

Relay Therapeutics (RLAY) Acquisitions (2021) Analysis & Trends

Relay Therapeutics (RLAY) has 1 years of Acquisitions data on file, last reported at $83000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Relay Therapeutics 3.43 Bn 3.43 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 83,000.00
Sep 30, 2021 83,000.00